» Articles » PMID: 35992598

Detecting Apathy in Patients with Cerebral Small Vessel Disease

Overview
Specialty Geriatrics
Date 2022 Aug 22
PMID 35992598
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Apathy is attracting more and more attention in clinical practice. As one of the most common features of cerebral small vessel disease (CSVD), the assessment of apathy still mainly relies on observers. With the development of Information and Communication Technologies (ICTs), new objective tools take part in the early detection of apathy.

Objectives: To detect apathy in patients with CSVD and find out the relationship between apathy and actigraphic data sampled from the diurnal and nocturnal periods.

Methods: A total of 56 patients with CSVD were recruited for a cross-sectional observational study. Apathy was diagnosed by the diagnostic criteria for apathy in neurocognitive disorders. The presence of lacunes, white matter hyperintensities, cerebral microbleeds (CMBs), and perivascular spaces (PVS) in magnetic resonance imaging (MRI) images were rated independently. Actigraph devices were worn in the non-dominant hands of each subject for 7 consecutive days to collect samples of raw data, and diurnal vector magnitude (VM) and a series of sleep quality variables were obtained.

Results: We found that the frequency of apathy in Chinese patients with CSVD reached 37.50%. Patients in the Apathy+ group showed more lacunes and CMBs, and higher Fazekas scores in comparison to apathy-group individuals. Diurnal VM, instead of other sleep quality variables, was lower in CSVD patients with apathy relative to those without apathy. Lastly, we discovered that diurnal VM and total time in bed (TTB) correlated negatively with apathy severity in patients with CSVD.

Conclusion: Actigraphy is a promising choice to evaluate apathy in patients with CSVD.

Citing Articles

Advances in the study of apathy related to cerebral small vessel disease.

Bu S, Hu X, Su Z, Li L Front Neurol. 2025; 16:1513574.

PMID: 40013000 PMC: 11860071. DOI: 10.3389/fneur.2025.1513574.


Cerebrospinal fluid amyloid-β and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients.

Zeng Q, Wang Y, Wang S, Luo X, Li K, Xu X Alzheimers Res Ther. 2024; 16(1):69.

PMID: 38570794 PMC: 10988961. DOI: 10.1186/s13195-024-01434-7.


Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2).

Blair G, Appleton J, Mhlanga I, Woodhouse L, Doubal F, Bath P Stroke Vasc Neurol. 2024; 9(6):581-594.

PMID: 38569894 PMC: 11791638. DOI: 10.1136/svn-2023-003022.


Association between behavioral and psychological symptoms and cerebral small vessel disease MRI findings in memory clinic patients.

Shinohara M, Matsuda K, Ii Y, Tabei K, Nakamura N, Hirata Y Front Aging Neurosci. 2023; 15:1143834.

PMID: 37032819 PMC: 10079999. DOI: 10.3389/fnagi.2023.1143834.

References
1.
Cosin C, Sibon I, Poli M, Allard M, Debruxelles S, Renou P . Circadian sleep/wake rhythm abnormalities as a risk factor of a poststroke apathy. Int J Stroke. 2014; 10(5):710-5. DOI: 10.1111/ijs.12433. View

2.
Robert P, Konig A, Andrieu S, Bremond F, Chemin I, Chung P . Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. J Nutr Health Aging. 2013; 17(8):653-60. DOI: 10.1007/s12603-013-0046-3. View

3.
Brown D, Barrett M, Flanigan J, Sperling S . Clinical and demographic correlates of apathy in Parkinson's disease. J Neurol. 2019; 266(2):507-514. DOI: 10.1007/s00415-018-9166-3. View

4.
Robert P, Lanctot K, Aguera-Ortiz L, Aalten P, Bremond F, Defrancesco M . Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur Psychiatry. 2018; 54:71-76. DOI: 10.1016/j.eurpsy.2018.07.008. View

5.
Mulin E, Zeitzer J, Friedman L, Le Duff F, Yesavage J, Robert P . Relationship between apathy and sleep disturbance in mild and moderate Alzheimer's disease: an actigraphic study. J Alzheimers Dis. 2011; 25(1):85-91. DOI: 10.3233/JAD-2011-101701. View